Bausch + Lomb Insider Trading

TSX BLCO

All Trades

Significant

Notable

Clusters

Repeat

Company	Insider	Title	Date	Shares	Price	Value	Balance	Increase	Signal
Bausch + Lomb	Bailey, Ambrose	CLO	06-Mar-26	14,600	$17.15^USD	$250,338	100,940	17%	SI SCL
Bausch + Lomb	Saunders, Brenton	CEO	06-Mar-26	14,700	$17.14^USD	$251,963	421,221	4%	NT SCL
Bausch + Lomb	Ross Sr., Thomas	Director	03-Mar-26	4,500	$17.68^USD	$79,556	17,000	36%	SI SCL
Bausch + Lomb	Von Eschenbach, Andrew	Director	27-Feb-26	4,364	$18.30^USD	$79,883	18,559	31%	SI CL
Bausch + Lomb	Collis, Steven	Director	23-Feb-26	15,000	$17.81^USD	$267,150	15,000	New	SI SCL
Bausch + Lomb	Robertson, Russel	Director	20-Feb-26	4,400	$17.90^USD	$78,760	10,208	76%	SI SCL
Bausch + Lomb	Ling, Karen	Director	19-Feb-26	4,000	$17.74^USD	$70,968	21,338	23%	SI SCL
Bausch + Lomb	Saunders, Brenton	CEO	22-May-25	22,000	$11.28^USD	$248,072	205,958	12%	SI

Stock Chart

Related Companies to Explore

Kane Biotech Inc.KNE Profound Medical Corp.PRN Kda GroupKDA Medexus PharmaceuticalsMDP Conavi MedicalCNVI

Company Info

Bausch + Lomb Corporation is a leading global eye health company headquartered in Vaughan, Ontario, Canada. One of the most recognized brands in the eye care industry with a history spanning over 170 years, Bausch + Lomb develops, manufactures, and markets a comprehensive portfolio of products including contact lenses, lens care products, ophthalmic pharmaceuticals, intraocular lenses, and surgical equipment. The company serves eye care professionals and consumers in over 100 countries worldwide. Bausch + Lomb was spun off from Bausch Health Companies and listed independently on the Toronto Stock Exchange under the ticker BLCO, providing investors with dedicated exposure to one of the world’s premier eye health franchises.